today
fast
grow
number
nucleic
acidbas
strategi
modul
vast
varieti
cellular
function
review
see
sever
class
oligonucleotid
like
aptam
transcript
factorbind
decoy
oligonucleotid
ribozym
triplexform
oligonucleotid
tfo
immunostimulatori
cpg
motif
antisens
oligonucleotid
includ
peptid
nucleic
acid
pna
small
interf
rna
sirna
antagomir
attain
much
interest
research
tool
owe
highli
specif
mode
action
even
import
oligomer
nucleic
acid
consider
potenti
use
therapeut
figur
provid
overview
oligonucleotid
target
site
within
cell
although
quit
differ
mode
action
oligomer
nucleic
acid
sever
featur
common
essenti
either
ration
design
eg
antisens
oligonucleotid
sirna
select
vitro
eg
aptam
ribozym
major
advantag
compar
tradit
small
molecul
drug
screen
approach
gener
macromolecul
show
remark
high
specif
target
accompani
low
probabl
gener
sideeffect
addit
nucleic
acid
virtual
nonimmunogen
compar
protein
peptidebas
approach
downsid
consider
like
stabil
bioavail
pharmacokinet
come
play
though
drawback
resolv
appropri
chemic
modif
nucleas
resist
instanc
achiev
alkyl
modif
ribos
recent
year
valuabl
progress
accomplish
develop
novel
chemic
modifi
nucleotid
improv
properti
enhanc
serum
stabil
higher
target
affin
low
toxic
pharmacokinet
paramet
ration
improv
increas
molecular
size
eg
sitespecif
conjug
polyethylen
glycol
peg
spite
major
obstacl
turn
oligomer
nucleic
acid
drug
effici
cellular
deliveri
due
limit
long
time
nucleic
acid
consid
signific
therapeut
prospect
though
effici
proven
countless
vitro
studi
obviou
dilemma
urgent
call
safe
effici
nucleic
acid
deliveri
system
essenti
nucleic
acid
deliveri
techniqu
avail
today
compris
variou
physic
chemic
method
viral
nonvir
vector
system
uptak
nake
nucleic
acid
figur
certain
advantag
disadvantag
might
appropri
particular
requir
fulfil
gener
physic
chemic
method
like
microinject
electropor
particl
bombard
well
calcium
phosphat
coprecipit
highli
effici
rather
harm
target
cell
lack
potenti
applic
vivo
gener
consent
viral
vector
system
effici
vehicl
deliv
nucleic
acid
cell
howev
despit
substanti
effort
last
year
research
fail
develop
suitabl
especi
safe
viral
system
review
see
contrari
field
experienc
sever
setback
caus
import
clinic
trial
put
hold
result
difficulti
encount
viral
vector
eg
mutagenesi
immun
respons
much
attent
paid
develop
allegedli
safer
nonvir
deliveri
system
concept
includ
assort
fairli
unrel
approach
yield
variou
degre
enhanc
cellular
uptak
nucleic
acid
current
liposom
cation
polym
use
standard
tool
transfect
cell
vitro
approach
yet
characteris
signific
lack
effici
accompani
high
level
toxic
render
mostli
inadequ
vivo
applic
peptid
act
shuttl
control
cellular
deliveri
nucleic
acid
repres
new
innov
concept
bypass
problem
poor
bioavail
clinic
efficaci
macromolecul
idea
use
peptid
carrier
goe
back
year
two
group
discov
chanc
transactiv
protein
tat
taken
mammalian
cell
year
later
antennapedia
homeodomain
drosophila
melanogast
shown
act
similarli
later
could
shown
peptid
deriv
tat
antennapedia
well
protein
capabl
transport
macromolecular
cargo
molecul
cell
base
promis
result
rapidli
expand
field
focus
socal
cellpenetr
peptid
cpp
also
refer
protein
transduct
domain
ptd
began
develop
review
report
recent
progress
field
peptidemedi
deliveri
nucleic
acid
highlight
develop
sever
new
cpp
discuss
mechan
cellular
internalis
addit
present
data
peptidemedi
sirna
deliveri
briefli
discuss
given
context
numer
cpp
describ
accord
origin
group
three
class
first
group
compris
cpp
origin
natur
occur
protein
protein
deriv
cpp
second
consist
chimer
cpp
compos
differ
protein
domain
third
class
encompass
socal
model
cpp
develop
accord
structurefunct
relationship
without
homolog
natur
sequenc
common
known
cpp
basic
amino
acid
caus
net
posit
charg
physiolog
ph
first
attempt
defin
peptid
cpp
follow
definit
establish
cpp
consist
less
amino
acid
ii
cpp
internalis
cell
seemingli
receptor
proteinindepend
process
even
iii
cpp
abl
mediat
deliveri
cargo
discuss
later
definit
longer
appropri
present
peptid
consid
cpp
show
abil
cross
biolog
membran
cargo
bound
cpp
coval
noncoval
coval
attach
achiev
either
express
fusion
construct
chemic
coupl
review
see
case
cargo
carrier
bind
noncoval
ionic
interact
depend
natur
bind
partner
assembl
nanoparticl
may
occur
despit
widespread
interest
peptid
carrier
mechan
underli
cellular
transloc
cpp
poorli
understood
subject
controversi
discuss
figur
earli
work
reli
upon
fluoresc
imag
flow
cytometri
analysi
chemic
fix
cell
examin
intracellular
localis
fluoresc
label
peptid
absenc
presenc
cargo
accord
experi
peptid
seem
internalis
rapidli
within
minut
even
observ
conclud
cpp
penetr
cell
membran
energyindepend
mechan
although
report
quit
earli
certain
fixat
procedur
may
caus
artefact
lead
overestim
cellular
uptak
rate
dimens
problem
commonli
recognis
side
side
comparison
fix
live
cell
publish
author
convincingli
demonstr
distribut
pattern
well
conjug
complet
differ
live
versu
fix
cell
stress
import
sourc
misinterpret
aris
experiment
difficulti
distinguish
cell
surfaceassoci
cpp
cpp
internalis
cytoplasm
compart
notabl
could
shown
endocytot
transport
key
compon
internalis
process
tat
deriv
peptid
penetratin
prior
endocytosi
cpp
interact
electrostat
extracellular
matrix
cell
surfac
mostli
bind
neg
charg
glycosaminoglycan
ie
heparan
sulfat
proteoglycan
eukaryot
cell
take
macromolecul
particl
surround
medium
process
call
endocytosi
besid
phagocytosi
relev
specialis
cell
like
macrophag
process
occur
cell
least
four
basic
mechan
macropinocytosi
clathrinmedi
endocytosi
caveolinmedi
endocytosi
clathrin
caveolinindepend
endocytosi
figur
review
see
mechanist
divers
highli
regul
endocyt
pathway
contribut
control
complex
physiolog
process
hormonemedi
signal
transduct
immun
surveil
antigenpresent
homeostasi
beststudi
endocytosi
pathway
clathrinco
pit
pathway
review
see
mani
receptor
associ
ligand
cluster
clathrinco
pit
associ
clathrin
adaptor
protein
foursubunit
complex
clathrin
adaptor
turn
bind
clathrin
lattic
thought
provid
forc
requir
deform
membran
curv
bud
larg
gtpase
dynamin
involv
pinch
coat
pit
form
clathrinco
vesicl
vesicl
uncoat
chaperon
dnaj
domain
cochaperon
auxillin
uncoat
endocyt
vesicl
fuse
one
anoth
earli
endosom
reaction
requir
small
gtpase
eventu
earli
late
endosom
transport
may
mediat
small
vesicular
intermedi
late
endosom
thought
fuse
prelysosom
form
hybrid
organel
matur
back
lysosom
sort
fission
second
best
studi
pathway
depend
caveolin
review
see
oligomeris
caveolin
associ
plasma
membran
protein
eg
ptrfcavin
lipid
form
stabl
function
unit
refer
caveola
caveolar
unit
also
maintain
stabl
structur
upon
endocytosi
bud
caveola
fuse
either
caveosom
manner
earli
endosom
manner
caveola
remain
plasma
membran
long
period
variou
agent
stimul
internalis
includ
viru
well
sterol
glycosphingolipid
use
caveola
entri
cell
stimul
caveolar
bud
despit
differ
agent
use
stimul
caveolar
internalis
common
mechan
involv
pathway
crucial
role
dynamin
src
kinas
protein
kinas
c
actin
recruit
besid
two
pathway
less
welldefin
pathway
ie
clathrin
caveolinindepend
lipidraft
endocytosi
differ
rout
describ
pathway
sever
characterist
common
remain
complic
precis
determin
endosom
rout
follow
part
attribut
fact
endocytosi
far
understood
detail
differenti
altern
endocytosi
pathway
involv
cellular
uptak
cargo
molecul
accomplish
use
small
molecul
inhibitor
colocalis
studi
specif
marker
follow
fluoresc
microscopi
cell
fraction
fate
cargo
eg
degrad
lysosom
storag
caveosom
transport
golgi
complex
er
etc
larg
depend
endocytosi
pathway
involv
uptak
would
highli
desir
induc
internalis
via
particular
pathway
order
better
control
traffick
cell
current
easili
achiev
howev
certain
paramet
influenc
mode
uptak
like
particl
size
interact
complex
cell
surfac
compon
well
physiolog
state
target
cell
respect
sever
option
manipul
cell
traffick
base
find
describ
mani
group
began
reexamin
data
howev
despit
consider
technic
improv
still
puzzl
controversi
result
concern
exact
mechan
cpp
uptak
though
case
endocytosi
suggest
main
rout
internalis
substanti
difficulti
encount
identifi
exact
pathway
recent
studi
indic
uptak
mechan
cpp
influenc
attach
cargo
exampl
richard
et
al
report
colocalis
marker
clathrinmedi
endocytosi
wherea
fittipaldi
et
al
found
caveolaelipid
raftdepend
process
tatgfp
fusion
protein
wadia
et
al
describ
macropinocytot
uptak
pathway
fusion
construct
tat
peptid
cre
recombinas
avoid
complex
inher
cell
culturebas
experi
biophys
investig
cppmembran
interact
differ
model
membran
perform
accord
kind
studi
direct
penetr
sever
cpp
lipid
layer
propos
howev
highli
problemat
transfer
data
cellular
level
natur
membran
compos
heterogen
mixtur
protein
lipid
includ
distinct
microdomain
lipid
raft
microdomain
enrich
cholesterol
sphingolipid
even
import
cell
surround
extracellular
matrix
consist
miscellan
protein
receptor
thu
obviou
simpl
model
membran
reflect
situat
nevertheless
studi
could
part
mimic
process
take
place
endosom
membran
might
help
understand
cpp
escap
vesicl
taken
togeth
conclud
precis
mechan
internalis
remain
elus
strongli
depend
properti
cpp
cargo
well
transfect
condit
cell
line
use
furthermor
reason
specul
multipl
pathway
involv
cellular
entri
block
one
altern
pathway
may
becom
activ
abil
transactiv
protein
tat
penetr
cellular
membran
first
discov
sinc
numer
report
describ
success
intracellular
transport
sever
macromolecular
cargo
includ
entir
protein
like
horseradish
peroxidas
coval
attach
protein
fragment
recent
review
see
vivo
cargo
protein
found
enzymat
activ
form
cell
sever
organ
includ
brain
test
differ
truncat
version
tat
vive
et
al
reveal
highest
transfect
effici
even
shorter
peptid
almost
exclus
compos
basic
amino
acid
prove
essenti
suffici
nuclear
import
mammalian
cell
guanidinium
group
shown
superior
cation
group
sequenc
conjug
tat
protein
peptid
pna
variou
class
oligonucleotid
sirna
shown
transloc
cell
moreov
transport
noncoval
bound
plasmid
dna
liposom
even
adenovir
particl
demonstr
penetratin
formerli
term
peptid
deriv
third
helix
drosophila
melanogast
antennapedia
homeodomain
protein
one
wide
investig
cpp
exert
low
toxic
high
transloc
rate
tat
transloc
effici
strongli
depend
certain
basic
residu
spite
retro
enantiomodifi
version
show
compar
properti
earlier
studi
interpret
evid
receptorindepend
uptak
mechan
contrast
et
al
recent
present
convinc
data
penetratin
abl
directli
travers
number
lipid
bilay
model
membran
accord
studi
cellular
uptak
penetratin
suppos
occur
via
endocyt
pathway
probabl
initi
electrostat
interact
cell
surfac
molecul
also
accord
vitro
studi
show
cellular
internalis
process
temperatur
well
energydepend
influenc
variou
endocytosi
inhibitor
meanwhil
numer
report
cellular
deliveri
coval
attach
cargo
like
protein
peptid
oligonucleotid
includ
pna
sirna
promis
result
recent
achiev
modifi
version
penetratin
concern
endosom
releas
internalis
sirna
attach
hexaarginin
nterminu
penetratin
concern
deliveri
splice
correct
pna
absenc
endosomolyt
agent
transportan
chimer
amino
acid
peptid
origin
develop
group
langel
compos
ntermin
amino
acid
neuropeptid
galanin
coupl
mastoparan
peptid
wasp
venom
strongli
interact
membran
trim
transportan
led
peptid
residu
display
similar
properti
initi
peptid
transportan
analogu
shown
deliv
protein
kda
plasmid
oligonucleotid
includ
sirna
pna
latter
applic
shown
two
independ
compar
studi
transportan
even
potent
deliv
conjug
pna
splice
correct
penetratin
tat
elucid
mechan
transloc
padari
et
al
studi
cellular
uptak
biotinyl
transportan
complex
label
avidin
conjug
transmiss
electron
microscopi
confoc
laser
scan
microscopi
internalis
process
temperaturedepend
ie
strongli
inhibit
block
complex
predominantli
observ
endocytot
vesicl
differ
morpholog
size
microscop
studi
perform
futaki
et
al
reveal
oligoarginin
argininerich
peptid
effici
taken
cell
molecul
highest
effici
turn
octaarginin
wherea
peptid
arginin
residu
show
neglig
transloc
studi
sever
branch
version
oligoarginin
indic
number
arginin
residu
much
import
structur
per
se
direct
comparison
nonam
compos
arginin
histidin
lysin
ornithin
reveal
arginin
residu
effect
penetr
plasma
membran
guanidinium
group
shown
apoptosisinduc
peptid
conjug
activ
hela
cell
transloc
furthermor
modifi
oligoarginin
use
noncoval
deliveri
plasmid
sirna
nakas
et
al
demonstr
macropinocytosisdepend
internalis
pathway
data
base
observ
ethylisopropylamilorid
eipa
macropinocytosi
specif
inhibitor
factin
polymeris
inhibitor
cytochalasin
significantli
suppress
uptak
addit
activ
rac
protein
rearrang
actin
cytoskeleton
observ
within
minut
incub
peptid
interestingli
flow
cytometri
analysi
reveal
internalis
similar
degre
penetratin
significantli
larger
extent
tat
peptid
model
amphipath
peptid
map
also
term
kla
peptid
deriv
amphipath
model
peptid
klalklalkalkaalkla
design
steiner
et
al
peptid
shown
internalis
multipl
nonspecif
energydepend
independ
process
sever
type
cell
addit
transport
coval
attach
short
peptid
pna
well
transport
oligonucleotid
attach
either
coval
noncoval
mammalian
cell
report
use
splice
correct
pna
differ
kla
analogu
wolf
et
al
analys
influenc
charg
structureform
properti
conjug
antisens
effect
variou
construct
unstructur
nonamphipath
neg
charg
peptid
pna
show
less
activ
moreov
replac
arginin
residu
lysin
improv
antisens
activ
cleavabl
disulfid
requir
effici
splice
correct
wherea
localis
peptid
nterminu
pna
crucial
attain
antisens
activ
predomin
portion
pnakla
conjug
seem
taken
endocytosi
coadministr
lysosomotrop
agent
well
photochem
treatment
promot
signific
enhanc
observ
antisens
effect
mpg
amino
acid
peptid
compos
hydrophob
domain
deriv
ntermin
fusion
sequenc
glycoprotein
hydrophil
domain
deriv
nuclear
localis
sequenc
nl
larg
tantigen
link
amino
acid
spacer
unlik
cpp
describ
today
peptid
need
coval
attach
cargo
molecul
complex
format
cargo
occur
ionic
interact
posit
charg
nl
sequenc
neg
charg
cargo
addit
depend
natur
cargo
hydrophob
interact
may
import
well
furthermor
hydrophob
peptidepeptid
interact
lead
format
nanoparticl
fluoresc
measur
reveal
appar
dissoci
constant
low
nanomolar
rang
nucleic
acidpeptid
interact
approxim
excess
posit
charg
mpg
shown
deliv
dna
oligonucleotid
plasmid
dna
sirna
mammalian
cell
recent
differ
deriv
mpg
describ
one
peptid
term
differ
amino
acid
hydrophob
part
oppos
origin
peptid
modif
lead
predominantli
structur
wherea
mpg
nonord
water
adopt
structur
contact
oligonucleotid
phospholipid
peptid
show
abil
insert
spontan
model
membran
phenomenon
propos
prerequisit
cellpenetr
activ
variat
hydrophob
part
origin
mpg
sequenc
led
pepfamili
peptid
design
deliveri
protein
peptid
pna
analogu
peptid
except
nonendosom
entri
mechan
propos
human
calcitonin
hct
amino
acid
peptid
hormon
involv
regul
calcium
homeostasi
therapeut
use
osteoporosi
bonerel
diseas
review
see
remark
direct
applic
hct
nasal
epithelium
propos
effect
intraven
inject
investig
sever
shorter
version
hct
reveal
shortest
fragment
taken
cell
probabl
via
endocytosi
attach
larg
tantigen
nl
side
chain
result
branch
peptid
show
abil
promot
internalis
plasmid
human
neuroblastoma
cell
format
complex
noncoval
interact
rate
transfect
significantli
higher
effici
observ
commerci
transfect
reagent
lf
linear
fusion
mechan
uptak
yet
resolv
detail
howev
studi
label
indic
lipid
raftmedi
endocytosi
perform
mani
cell
line
rather
low
concept
optimis
lead
sever
branch
hctderiv
peptid
effici
transfect
noncoval
complex
plasmid
highest
peptid
branch
consist
two
nl
call
part
truncat
form
peptid
amino
acid
furthermor
cell
line
specif
differ
becam
obviou
studi
show
highest
transfect
rate
hek
cell
rat
hippocamp
neuron
wherea
effici
neuroblastoma
cell
primari
chicken
cardiomyocyt
current
branch
peptid
test
noncoval
deliveri
aptam
sirna
addit
coupl
analogu
modif
damino
acid
synthesis
show
improv
metabol
stabil
cell
cultur
human
blood
also
rat
consist
amino
acid
includ
seven
arginin
residu
deriv
cterminu
tumor
suppressor
protein
invert
short
part
cellpenetr
properti
found
chanc
appli
control
peptid
activ
studi
arf
protein
fitclabel
streptavidin
taken
cell
format
noncoval
complex
author
abl
reduc
rel
high
concentr
achiev
much
higher
degre
protein
uptak
biotinyl
peptid
improv
streptavidin
bind
addit
peptid
also
deliv
conjug
pna
cell
concentr
peptidepnaconjug
deliveri
rate
significantli
higher
penetratin
well
tat
transportan
previous
analys
assay
chloroquin
led
slight
enhanc
biolog
effect
mediat
applic
endocytosi
inhibitor
cytochalasin
wortmannin
suggest
micropinocytosi
involv
cellular
uptak
hela
cell
colocalis
studi
fluoresc
label
indic
peptid
take
differ
entri
rout
differ
cell
line
signific
toxic
detect
concentr
neither
perturb
plasma
membran
influenc
cell
prolifer
measur
peptid
may
potenti
vivo
studi
sweet
arrow
peptid
sap
deriv
prolinerich
ntermin
repetit
domain
gammazein
storag
protein
maiz
shown
interact
membran
polyprolin
adopt
well
defin
helic
structur
polyprolin
ii
water
conserv
even
peptid
contain
prolin
residu
therefor
possibl
gener
amphipath
helix
introduc
polar
amino
acid
certain
posit
first
compar
studi
show
sequenc
vrlppp
name
sap
effici
cellular
uptak
albeit
rather
high
concentr
peptid
cellular
entri
nonclass
clathrinindepend
pathway
lipid
raftmedi
endocytosi
propos
aim
increas
hydrophob
sap
either
modifi
myrist
acid
one
prolin
residu
replac
gamma
dimethylsila
prolin
desir
modif
led
increas
cellular
uptak
factor
respect
moreov
fulli
proteas
resist
version
ie
alld
sap
synthesis
order
increas
stabil
peptid
analogu
retain
cellpenetr
activ
henc
investig
preliminari
uptak
studi
mice
fact
h
intraperiton
inject
nmol
peptid
uptak
leukocyt
sever
organ
kidney
liver
spleen
demonstr
although
bioactiv
cargo
introduc
far
studi
emphasis
use
damino
acid
vivo
approach
addit
corrobor
fact
cytotox
detect
least
mm
sapanalogu
compos
amino
acid
deriv
dermaseptin
peptid
larg
tantigen
nl
dermaseptin
constitut
larg
famili
polycation
antimicrobi
peptid
amino
acid
express
skin
certain
tree
frog
peptid
adopt
amphipath
structur
apolar
solvent
structur
featur
shown
mediat
cell
permeabilis
upon
specif
interact
phospholipid
cellular
membran
first
propos
penetr
intact
hela
cell
nonendocytot
process
accumul
nuclei
howev
later
peptid
report
internalis
endocytosi
low
concentr
independ
endocytosi
high
concentr
biophys
studi
compar
two
analogu
peptid
reveal
format
helic
structur
upon
peptidelipid
interact
depend
order
amino
acid
peptid
author
suggest
higher
content
helic
conform
allow
direct
penetr
cellular
membran
compar
confoc
microscopi
uptak
peptid
analogu
hela
cell
confirm
correl
helic
conform
nonendocytot
uptak
demonstr
equal
distribut
peptid
throughout
cytoplasm
nucleu
versu
vesicular
pattern
observ
mano
et
al
cellpenetr
properti
report
peptid
deriv
unprocess
nterminu
mous
prion
protein
mprpp
studi
mprpp
alon
coupl
fluoresc
label
avidin
internalis
mous
neuroblastoma
cell
show
diffus
punctuat
fluoresc
cytosol
h
incub
recent
cellular
uptak
also
shown
peptid
deriv
bovin
prion
protein
bprpp
prion
deriv
peptid
membran
perturb
effect
analys
number
vesicl
model
system
result
indic
peptideinduc
structur
defect
membran
similar
pore
though
overal
integr
vesicl
affect
furthermor
macropinocytosi
suggest
main
mechan
uptak
bprpp
trigger
bind
cellsurfac
proteoglycan
prion
deriv
peptid
known
perturb
cellular
membran
detail
toxic
studi
publish
far
noncoval
complex
approach
bprpp
prove
compet
deliveri
plasmiddna
well
sirna
cell
bioactiv
form
protein
play
import
role
dna
repair
found
bind
x
protein
bax
member
famili
protein
therebi
inhibit
apoptosi
activ
function
sever
pentapeptid
baxinhibit
peptid
deriv
differ
speci
retain
inhibit
properti
addit
featur
cellpenetr
activ
human
peptid
sequenc
vpmlk
pmlke
well
sequenc
mous
vptlk
rat
vpalr
test
cellpenetr
date
pentapeptid
term
categoris
shortest
cpp
order
avoid
baxinhibit
properti
amino
acid
exchang
invert
produc
cpp
sequenc
ipmik
klpvm
klpvt
nontox
concentr
mm
uptak
rang
cell
line
also
primari
cell
demonstr
fac
confoc
microscopi
mode
entri
cell
howev
well
potenti
involv
cellular
receptor
still
unknown
far
test
endocytosi
inhibitor
perform
extrem
high
concentr
famlabel
peptid
show
signific
blockag
uptak
cell
cultur
studi
low
temperatur
led
promin
reduct
cellular
import
complet
inhibit
thu
point
involv
energydepend
independ
mechan
vptlk
klpvm
fuse
cterminu
gfpprotein
success
carri
cargo
hela
cell
addit
simpl
cppbase
deliveri
system
compos
singl
peptid
trend
develop
system
higher
complex
main
goal
approach
gener
nanoparticl
defin
properti
eg
size
charg
distribut
well
provid
cellspecif
function
especi
import
vivo
use
sinc
comprehens
descript
recent
develop
would
far
beyond
scope
articl
give
exampl
gener
attempt
combin
peptid
cation
liposom
polyethyleneimin
pei
applic
aim
toward
synthesi
high
low
molecular
weight
branch
polym
andor
peptid
dendrim
recent
develop
even
complex
system
particularli
promis
respect
vivo
deliveri
three
advanc
approach
describ
detail
first
exampl
branch
polym
consist
altern
histidin
lysin
start
linear
hkpeptid
hkpolym
vari
number
branch
develop
show
high
serum
stabil
effici
deliv
plasmid
cultur
cell
even
tumour
use
mous
model
interestingli
differ
type
branch
prove
specif
advantag
sirna
deliveri
second
exampl
tatgraft
pegyl
nanocarri
carrier
success
appli
nucleic
acid
drug
deliveri
sever
cell
type
also
mous
model
order
select
direct
deliveri
cell
certain
surfac
antigen
e
g
tumour
cell
antibodi
conjug
peg
moieti
review
tatmodifi
nanocarri
see
one
latest
develop
torchilin
group
combin
tat
phsensit
hydrazon
bondbas
pegphosphatidylethanolamineconjug
undergo
selfassembl
form
micel
aqueou
solut
ph
lower
nanocarri
lose
peg
coat
result
exposur
tat
therefor
acid
microenviron
like
found
tumour
ischem
tissu
specif
target
nanocarri
cargo
enter
target
cell
moreov
hydrolyt
stabil
adjust
select
particular
hydrazon
substitu
third
exampl
describ
equal
complex
versatil
deliveri
system
multifunct
envelopetyp
nano
devic
mend
dna
packag
approach
develop
accord
ration
strategi
take
account
stabil
particl
entri
cell
well
releas
cargo
cytoplasm
nucleu
particl
resembl
much
envelop
viru
polycationcondens
dna
core
lipid
envelop
addit
modular
system
chang
supplement
meet
differ
need
pegyl
vivo
studi
helper
lipid
like
dioleoylphosphatidylethanolamin
dope
cholesteryl
hemisuccin
chem
integr
promot
endosom
releas
nuclear
import
cargo
wherea
introduct
envelop
serv
trigger
macropinocytosi
particl
differ
size
particl
chang
mechan
uptak
importantli
effici
plasmid
dna
deliveri
system
compar
adenoviru
without
induc
cytotox
addit
success
deliveri
report
sirna
antisens
oligonucleotid
assembl
differ
type
versatil
modular
system
prove
studi
aim
specif
target
skelet
muscl
heptapeptid
irq
integr
mend
surfac
peptid
sequenc
irqrrrr
discov
vivo
phage
display
novel
ligand
skelet
muscl
surprisingli
trigger
endocytosi
irqmend
via
caveola
oppos
author
show
encapsul
sirna
import
cell
readili
set
free
endosom
use
fusogen
lipid
envelop
mend
combin
ligand
tumourhom
peptid
describ
et
al
recognis
specif
surfac
antigen
mend
deliveri
system
offer
possibl
develop
celltyp
specif
therapeut
strategi
date
mani
exampl
cppmediat
deliveri
plasmid
dna
cultur
cell
also
vivo
due
size
plasmid
result
high
number
neg
charg
noncoval
approach
prove
feasibl
shown
tat
peptid
bind
dna
well
polyanion
form
complex
interact
membran
differ
cell
follow
internalis
endocytosi
accord
microscop
studi
tat
peptidedna
complex
accumul
acid
vesicl
eventu
set
free
appli
similar
approach
ignatovich
et
al
observ
moder
report
gene
express
incub
cultur
cell
tat
peptideplasmid
complex
hand
intraven
inject
complex
mice
yield
low
express
level
predominantli
liver
distribut
plasmid
dna
express
level
differ
significantli
obtain
nake
dna
attribut
mainli
nonspecif
hepat
uptak
macromolecular
compound
well
rapid
clearanc
due
interact
serum
albumin
furthermor
rudolph
et
al
present
data
support
noncoval
plasmid
dna
complex
format
oligomer
dimer
trimer
found
effici
tetram
anoth
intrigu
studi
compar
potenti
high
molecular
weight
form
tat
tat
peptid
form
stabl
noncoval
cell
transfect
complex
plasmid
dna
socal
polytat
consist
mixtur
linear
polym
tat
peptid
molecul
cross
link
disulfid
bridg
diamet
complex
determin
rang
nm
contrast
complex
consist
monomer
tat
peptid
plasmid
dna
tend
aggreg
much
bigger
particl
polytat
yield
increas
transfect
rate
compar
monomer
tat
could
increas
addit
lysosomotrop
reagent
chloroquin
even
exceed
level
peimedi
transfect
author
hypothesis
polytat
promot
format
stabl
complex
expos
free
basic
amino
acid
surfac
therebi
increas
transfect
effici
system
develop
form
reduc
layerbylay
film
plasmid
dna
self
assembl
process
yet
test
deliveri
though
idea
construct
carrier
system
sever
tat
peptid
monom
new
year
found
branch
peptid
contain
tat
moieti
consider
transfect
potenti
investig
branch
presenc
chloroquin
reveal
differ
cell
line
altern
pathway
intracellular
traffick
might
relev
plasmid
deliveri
low
transfect
effici
could
increas
two
order
magnitud
attach
stearyl
group
nterminu
probabl
due
amphipath
charact
modifi
peptid
reach
level
plasmid
transfect
lf
similar
result
obtain
endocytosi
propos
mechan
uptak
anoth
exampl
peptid
mpg
interact
posit
charg
nl
sequenc
neg
charg
plasmid
dna
peptidenucl
acid
complex
report
taken
effici
mammalian
cell
noncoval
complex
prion
protein
deriv
peptid
bprpp
plasmid
dna
led
endocytot
uptak
particl
protein
express
plasmid
express
level
howev
much
lower
measur
lfmediat
transfect
even
peptid
concentr
similarli
none
branch
human
calcitonin
deriv
could
reach
transfect
rate
cell
line
hek
hela
sknmc
primari
cell
although
branch
peptid
effici
transfect
rate
seen
even
test
presenc
chloroquin
optim
peptideplasmid
charg
ratio
fluoresc
microscop
localis
studi
led
conclus
branch
cpp
deliv
plasmid
cell
via
endocytosi
unsatisfi
extent
endosom
escap
interestingli
protein
express
level
neuroblastoma
cell
higher
transfect
novel
argininegraft
polym
gene
deliveri
low
cytotox
develop
kim
et
al
copolym
consist
two
pamam
moieti
separ
peg
flank
arginin
residu
form
nanos
polyplex
plasmid
deliv
variou
cell
line
precursor
polym
lack
arginin
show
minor
capabl
promot
gene
express
deliv
plasmid
presum
escap
endosom
contrast
transfect
arginin
modifi
polym
led
significantli
enhanc
gene
express
base
upon
extens
studi
inhibitor
endocytosi
author
suggest
deliveri
system
enter
cell
via
combin
pathway
literatur
current
avail
seem
vivo
studi
cppbase
polym
complex
system
prefer
oppos
simpl
cpp
approach
give
exampl
histidinelysinepolym
prove
use
plasmid
deliveri
sever
cell
line
well
mous
model
comparison
version
branch
system
highest
effici
vivo
system
administr
luciferas
plasmid
mice
xenograft
tumour
gene
express
mostli
detect
lung
spleen
addit
tumour
tissu
two
model
differ
growth
rate
tumour
size
significantli
reduc
transfect
plasmid
encod
antitumour
gene
alreadi
mention
chapter
polym
complex
system
multifunct
envelopetyp
nano
devic
mend
mimic
viru
particl
order
compar
transfect
effici
differ
mend
type
gene
deliveri
dna
code
luciferas
use
cargo
sever
differ
combin
peptid
lipid
test
cell
cultur
highest
luciferas
activ
achiev
polyllysinedna
particl
coat
endosomolyt
lipid
impress
effici
transfect
method
compar
adenoviru
without
induc
cytotox
addit
author
present
success
gene
deliveri
hair
follicl
mice
topic
applic
rate
transfect
much
higher
achiev
lf
far
common
use
oligonucleotid
inhibitor
gene
express
socal
antisens
approach
review
see
antisens
oligonucleotid
complementari
rna
interest
therefor
specif
mediat
watsoncrick
base
pair
oligonucleotid
target
rna
three
principl
way
antisens
oligonucleotid
use
disrupt
protein
product
oligonucleotiderna
duplex
may
form
substrat
endogen
rnase
h
lead
mrna
cleavag
ii
oligonucleotiderna
duplex
may
prevent
product
assembl
ribosom
complex
arrest
ribosom
complex
alreadi
engag
translat
case
affect
protein
biosynthesi
iii
oligonucleotiderna
duplex
may
alter
premrna
splice
nucleu
earli
studi
demonstr
antisens
oligonucleotidemedi
effect
ie
inhibit
neurit
growth
via
downregul
amyloid
precursor
protein
cell
death
downregul
cuzn
superoxid
dismutas
perform
penetratindna
conjug
addit
conjug
tat
peptid
penetratin
phosphorothio
modifi
oligonucleotid
effect
antisens
inhibit
pglycoprotein
express
membran
atpas
associ
multidrug
resist
tumour
cell
howev
peptidebas
deliveri
studi
antisens
oligonucleotid
conduct
peptid
nucleic
acid
pna
pna
nucleic
acid
mimic
ribosephosph
skeleton
exchang
simpler
polyamid
backbon
pna
bind
singlestrand
dna
rna
high
affin
sequenc
specif
furthermor
pna
bind
doublestrand
dna
uniqu
mechan
socal
strand
invas
addit
remark
hybridis
properti
pna
resist
nucleas
proteas
lack
anomer
carbon
atom
standard
amino
acid
owe
inabl
activ
rnase
h
contrast
unmodifi
antisens
oligonucleotid
pna
mere
act
steric
block
first
studi
show
cppmediat
antisens
activ
pna
conduct
pooga
et
al
suppress
galanin
receptor
express
cell
cultur
well
rat
model
achiev
coupl
correspond
pna
penetratin
transportan
addit
report
pna
coupl
transportan
target
transactiv
respons
region
tar
rna
effici
internalis
cultur
cell
examin
function
efficaci
pnatransportan
conjug
cell
cultur
use
luciferas
report
gene
assay
reveal
signific
inhibit
tatmedi
transactiv
long
termin
repeat
furthermor
conjug
substanti
inhibit
product
chronic
infect
cell
recent
pna
almost
ident
sequenc
disulfidelink
either
transportan
chimer
peptid
shown
exhibit
dosedepend
inhibit
tatmedi
transactiv
hela
cell
assay
incub
h
chloroquin
coadminist
transactiv
activ
alreadi
reach
within
h
interestingli
fluoresceinlabel
stabli
link
conjug
tat
transportan
pna
inact
deliv
alon
attain
transactiv
inhibit
presenc
chloroquin
data
present
indic
cleavabl
bond
essenti
activ
assay
moreov
confoc
microscopi
show
fluoresc
label
cpppna
conjug
sequest
endosom
membranebound
compart
hela
cell
vari
appear
depend
cpp
coadministr
chloroquin
seen
case
releas
fluoresc
compart
nucleu
differ
pattern
depend
cpp
find
turner
et
al
inconsist
observ
tripathi
et
al
latter
suggest
nonendocytot
pathway
uptak
disulfidelink
conjug
antitar
pna
sever
cpp
illustr
flow
cytometri
analysi
addit
inhibitori
effect
replic
valu
submicromolar
rang
well
viricid
activ
low
nanomolar
rang
conjug
test
report
recent
evalu
pharmacokinet
properti
antitar
pnapenetratin
conjug
balbc
mice
conclud
construct
nontox
concentr
rang
predict
futur
therapeut
use
use
improv
purif
protocol
turner
et
al
synthesis
sever
cppconjug
rna
oligonucleotid
ome
omelock
nucleic
acid
lna
mixmer
well
omephosphorothio
rna
oligom
target
tar
although
oligonucleotid
previous
shown
activ
transactiv
assay
cation
lipofect
activ
detect
highli
pure
conjug
agreement
vesicular
uptak
nuclear
import
observ
confoc
microscopi
order
gener
net
posit
charg
conjug
addit
basic
amino
acid
introduc
peptid
sequenc
enhanc
bioavail
oligonucleotid
either
interestingli
rate
uptak
dramat
enhanc
addit
free
cpp
conjug
though
still
biolog
activ
observ
indic
possibl
lack
endosom
escap
author
suggest
free
cpp
form
complex
cppcargo
conjug
play
signific
role
uptak
process
conclud
care
taken
conjug
purif
furthermor
studi
show
uptak
pattern
strongli
depend
cell
line
analys
astriabfish
et
al
describ
deliveri
ome
rna
phosphorothio
oligonucleotid
link
via
disulfid
bridg
tat
peptid
penetratin
biolog
readout
splice
correct
assay
appli
assay
use
antisensemedi
rescu
introduc
aberr
splice
site
otherwis
lead
inact
report
enzym
case
luciferas
approach
particularli
interest
sinc
report
gene
activ
turn
rather
turn
upon
applic
appropri
antisens
oligonucleotid
thu
neg
effect
caus
experiment
constraint
lead
reduc
protein
express
due
appli
nucleic
acid
caus
fals
interpret
experiment
data
cppoligonucleotid
conjug
progress
enter
cell
matter
hour
detect
cytoplasm
vesicl
nucleu
conjug
target
aberr
splice
site
mismatch
control
caus
increas
luciferas
activ
doserespons
manner
find
contrast
result
turner
et
al
describ
could
find
biolog
effect
discrep
may
simpli
due
differ
two
biolog
assay
phosphorodiamid
morpholino
oligom
pmo
similar
dna
two
major
structur
differ
neg
charg
phosphorodiest
internucleosid
linkag
dna
replac
neutral
phosphorodiamid
linkag
fivememb
ring
deoxyribos
dna
replac
sixmemb
ring
morpholin
uncharg
hydrophil
pmo
highli
resist
enzymat
degrad
use
splice
correct
assay
describ
moulton
et
al
could
show
missplic
premrna
correct
upon
addit
conjug
cell
cultur
medium
low
micromolar
concentr
deliveri
pmo
cell
nucleu
cytosol
requir
conjug
rather
complex
peptid
pmo
furthermor
argininerich
peptid
show
higher
transfect
rate
conjug
tat
peptid
penetratin
tat
peptid
analogu
comparison
conjug
variou
linker
reveal
increas
antisens
activ
conjug
longer
spacer
wherea
variat
conjug
chemistri
result
differ
addit
studi
group
show
inhibit
coronaviru
flaviviru
dengu
viru
west
nile
viru
replic
cppmediat
antisens
pmo
deliveri
besid
addit
chloroquin
differ
endosom
disrupt
strategi
evalu
use
splice
correct
assay
exampl
cotreat
endosomedisrupt
peptid
photochem
internalis
howev
promis
result
especi
concern
futur
vivo
applic
steric
block
oligonucleotid
achiev
two
newli
develop
deriv
classic
cpp
review
modif
oligoarginin
nonnatur
uncharg
amino
acid
led
amongst
other
peptid
rahxr
ahx
repres
sixatom
aminohexano
acid
spacer
abe
et
al
demonstr
contrast
tat
oligoargin
pmoconjug
peptid
led
dosedepend
splice
correct
low
micromolar
concentr
absenc
endosomolyt
agent
underli
mechan
superior
activ
clear
yet
uptak
rahxr
construct
less
effici
uptak
tat
oligoarginin
construct
also
involv
endocytot
rout
second
peptid
deriv
penetratin
six
arginin
residu
ad
nterminu
conjug
shown
inhibit
tatdepend
transactiv
well
promot
effici
splice
correct
case
low
concentr
absenc
endosomolyt
agent
uptak
seem
involv
endocytosi
nearli
differ
splice
correct
activ
regardless
natur
linker
use
conjug
like
stabl
thioether
versu
reduc
disulfid
linker
cpppmo
pnaconjug
begin
advanc
research
tool
therapeut
applic
vivo
efficaci
alreadi
demonstr
mous
model
muscular
dystrophi
coronaviru
infect
use
anoth
variant
rahxr
describ
refer
therein
regard
anoth
interest
approach
follow
morri
et
al
use
neg
charg
pnalik
dna
mimic
call
hypnappna
consist
phosphon
analogu
pna
pnalik
monom
basi
base
previou
peptid
pep
famili
group
design
new
cpp
form
stabl
complex
charg
well
uncharg
pna
effici
cellular
uptak
antisens
hypnappna
demonstr
via
downregul
cyclin
hela
cell
well
suspens
primari
cell
furthermor
mous
xenograft
tumour
model
human
prostat
carcinoma
use
analys
vivo
deliveri
complex
intraven
administr
reduc
tumour
growth
approxim
intratumour
inject
specif
concentrationdepend
inhibit
tumour
growth
detect
could
improv
stabilis
complex
pegyl
nterminu
microrna
mirna
conserv
class
small
noncod
rna
particip
posttranscript
regul
mani
cellular
process
also
involv
emerg
tumour
metabol
diseas
specif
mirnasilenc
achiev
administr
antisens
oligonucleotid
call
antagomir
along
line
fabani
et
al
investig
block
activ
pna
conjug
penetratin
describ
knockdown
low
level
incub
inhibitori
construct
verifi
northern
blot
analys
well
upregul
mrna
normal
neg
regul
strikingli
incub
unconjug
pna
modifi
lysin
residu
led
complet
knockdown
cellular
uptak
similar
pnali
oligonucleotid
observ
earlier
case
appar
suffici
obtain
desir
biolog
activ
nucleu
doublestrand
transcript
factor
decoy
oligonucleotid
power
tool
modul
gene
express
decoy
compet
respons
element
within
promot
region
gene
bind
transcript
factor
coupl
specif
decoy
either
transportan
fisher
et
al
could
show
effici
cellular
transloc
construct
go
along
inhibit
interleukin
il
activ
downstream
effect
coupl
achiev
hybridis
pna
decoy
contain
correspond
singl
strand
overhang
pna
link
cpp
via
disulfid
bridg
recent
author
appli
principl
model
alzheimersdiseas
primari
rat
glial
cell
much
harder
transfect
result
inhibit
bind
activ
lead
decreas
mrna
express
use
similar
approach
elandaloussi
et
al
present
uptak
experi
compar
effect
myc
decoy
either
coval
noncoval
attach
myc
protein
shown
overexpress
human
tumour
known
today
well
characteris
repres
favour
target
anticanc
therapi
besid
biolog
effect
intracellular
amount
decoy
determin
fluoresc
measur
compar
noncoval
complex
decoy
oligonucleotid
taken
less
hybridis
conjug
howev
correl
biolog
activ
conjug
less
effect
intriguingli
variou
endocytosi
inhibitor
effect
rate
internalis
suggest
peptidecargo
complex
bypass
endosom
pathway
larg
extent
therefor
low
bioavail
must
caus
unknown
intracellular
process
tripl
helixform
oligonucleotid
tfo
bind
third
strand
major
groov
duplex
dna
form
triplex
dna
sequencespecif
manner
review
see
attract
applic
tfo
approach
includ
inhibit
target
gene
also
induct
point
mutat
predetermin
site
tfo
coupl
penetratin
disulfid
linkag
shown
internalis
cell
approach
report
gene
encod
amber
suppressor
trna
use
target
number
mutat
induc
tfo
determin
help
e
coli
strain
express
amber
mutat
treatment
cultur
mous
cell
rate
mutat
document
enhanc
factor
compar
basal
level
confoc
microscopi
studi
confirm
uptak
nucleu
also
reveal
sequenc
oligonucleotid
cargo
affect
effici
deliveri
pattern
intracellular
distribut
e
g
higher
gccontent
seem
reduc
nuclear
accumul
addit
antisens
applic
describ
sirna
repres
valuabl
antisens
tool
inhibit
express
target
gene
sequencespecif
manner
small
rna
molecul
induc
process
term
rna
interfer
rnai
result
mrna
degrad
review
see
first
studi
cppmediat
deliveri
sirna
publish
simeoni
et
al
sirna
noncoval
complex
peptid
mpg
lead
strong
regul
target
protein
interestingli
mutat
nl
sequenc
carrier
peptid
result
slight
increas
rnai
effect
sirna
associ
mpg
ratio
neg
posit
charg
appli
hela
cell
decreas
luciferas
activ
detect
effect
enhanc
studi
describ
coval
attach
cargo
carrier
one
approach
antigfp
sirna
crosslink
signific
downregul
target
protein
could
observ
high
concentr
nucleic
acid
nm
simpl
mix
sirna
tat
peptid
lead
measur
rnai
effect
lf
transfect
result
perinuclear
localis
sirna
contrast
fluoresc
label
without
cargo
mainli
found
nucleolu
signific
increas
rate
uptak
sirna
target
luciferas
gfp
could
observ
disulfid
coupl
sens
strand
penetratin
transportan
compar
slightli
higher
level
transfect
achiev
interestingli
transfect
basal
luciferas
activ
return
normal
level
one
day
earlier
cppmediat
transfect
although
concentr
sirna
appli
remark
strong
rnai
effect
hard
transfect
primari
neuron
cell
report
davidson
et
al
sirna
direct
sever
endogen
protein
coupl
penetratin
via
disulfid
bond
observ
regul
target
protein
peptidemedi
sirna
deliveri
found
far
effect
compar
part
attribut
toxic
lipid
dowdi
group
present
rather
critic
point
view
refer
previou
studi
cppsirnaconjug
claim
success
deliveri
describ
therein
sole
result
excess
free
peptid
lead
addit
complex
therebi
cellular
import
sirna
accord
turner
et
al
first
observ
care
purif
cppantisenseconjug
abrog
biolog
effect
lundberg
et
al
ration
modifi
penetratin
form
cpp
term
improv
endosomolyt
properti
achiev
phdepend
conform
chang
peptid
higher
degre
helic
replac
two
basic
amino
acid
histidin
ntermin
addit
six
amino
acid
studi
sever
cpp
compar
noncoval
approach
measur
overal
cellular
uptak
via
fluoresc
biolog
effect
sirna
target
luciferas
mrna
penetratin
well
transfect
lead
silenc
luciferas
gene
express
despit
high
amount
intracellular
sirna
contrast
previou
achiev
sirnapenetratinconjug
show
improv
deliveri
reduct
luciferas
activ
approxim
nm
sirna
peptid
also
induc
rnai
cell
achiev
transfect
protocol
chang
ie
preincub
volum
increas
emphasis
differ
uptak
properti
differ
cell
line
describ
earlier
addit
phsensit
peptid
deriv
haemagglutinin
promot
endosom
escap
author
link
penetratin
turn
although
improv
silenc
effect
coincub
penetratin
potent
combin
peptid
togeth
confoc
microscopi
studi
author
conclud
lack
biolog
effect
penetratinmedi
sirna
deliveri
due
lack
endosom
escap
superior
endosomolyt
activ
comparison
addit
bprpp
analys
studi
three
peptid
much
lower
silenc
effect
seen
compar
transfect
nm
sirna
recent
studi
nakamura
et
al
report
condens
sirna
type
posit
charg
agent
polyllysin
protamin
sirna
core
packag
lipid
envelop
form
shown
particl
sirna
yield
smallest
complex
effici
silenc
effect
hela
cell
concentr
nm
sirna
gene
silenc
achiev
transfect
core
lack
lipid
envelop
lead
biolog
effect
probabl
due
ineffici
endosom
escap
spite
anoth
studi
provid
evid
particl
alon
elicit
rnai
primari
rat
neuron
cell
promis
result
prospect
cell
specif
sirna
deliveri
present
leng
et
al
attempt
optimis
branch
histidinelysinepolym
sirna
deliveri
author
found
differ
branch
version
yield
knockdown
target
gene
sever
cell
type
branch
hand
turn
suitabl
carrier
plasmid
sirna
structurefunct
studi
reveal
import
role
composit
histidinerich
domain
well
posit
within
peptid
branch
sirna
deliveri
wherea
size
surfac
charg
effect
furthermor
toxic
much
lower
commerci
cation
lipid
oligofectamin
attach
tripeptid
rgd
integrinligand
slightli
enhanc
sirna
deliveri
turn
carrier
cellspecif
system
one
first
group
report
penetratinmedi
sirna
deliveri
vivo
moscho
et
al
show
intratrach
administr
conjug
lead
intensif
knockdown
target
gene
mitogenactiv
protein
kinas
mous
lung
comparison
unmodifi
nonformul
sirna
give
overview
vivo
studi
sirna
alon
sever
nonpeptid
carrier
system
show
even
unmodifi
nonformul
sirna
exert
signific
silenc
effect
strikingli
found
peptid
alon
trigger
detect
decreas
target
gene
express
penetratinconjug
induc
elev
level
immun
marker
lung
tissu
emphasis
conclus
easili
extrapol
vitro
experi
appli
vivo
situat
experiment
condit
care
control
meanwhil
cppmediat
sirna
deliveri
shown
success
least
vivo
studi
one
subcutan
inject
sirna
noncoval
complex
cholesteryl
oligodarginin
mous
model
success
target
angiogen
growth
factor
vegf
vascular
endotheli
growth
factor
seventeen
day
postadministr
target
protein
express
tumour
decreas
approxim
importantli
tumour
regress
factor
measur
long
known
peptid
deriv
rabi
viru
glycoprotein
rvg
interact
specif
nicotin
acetylcholin
receptor
achr
neuron
cell
enabl
viral
entri
recent
kumar
et
al
use
specif
deliveri
approach
brain
remark
biotinyl
form
peptid
ytiwmpenprpgtpcdiftnsrgkrasng
taken
neuron
cell
brain
inject
mice
order
transport
nucleic
acid
vehicl
conjug
rvg
peptid
system
treatment
mice
sirna
noncoval
complex
modifi
peptid
promot
highli
specif
cellular
import
sirna
cell
express
achr
even
import
antivir
sirna
treatment
result
success
protect
mice
enceph
caus
japanes
enceph
viru
jev
first
studi
report
nontox
method
deliv
sirna
across
blood
brain
barrier
could
help
circumv
danger
ineffect
inject
brain
date
present
one
promis
deliveri
approach
might
expand
vivo
applic
far
cppmediat
transfect
mirna
report
shown
primari
microrna
primirna
compris
nucleotid
transfer
nucleu
hela
cell
complex
call
reduc
copolypeptid
rcpp
linear
deliveri
system
compos
lysinecontain
histidinerich
peptid
hrp
larg
tantigen
nl
randomli
connect
via
disulfid
bond
develop
manickam
et
al
plasmid
deliveri
intranuclear
process
primirna
matur
mirna
possibl
polym
contain
suffici
portion
nl
moieti
author
also
studi
effici
rcpp
cellular
deliveri
sirna
turn
low
nlscontent
polyplex
favour
posttranscript
cytoplasm
rnai
wherea
higher
nlscontent
promot
nuclear
deliveri
thu
sirnamedi
promot
silenc
enabl
even
excel
effici
commerci
transfect
reagent
transittko
exampl
cppmediat
deliveri
nucleic
acid
becom
obviou
case
deliveri
system
must
adjust
sort
nucleic
acid
transfect
enorm
differ
size
number
charg
oligonucleotid
plasmid
dna
lead
differ
mechan
noncoval
particl
format
partli
explain
cargodepend
discrep
found
also
lipid
carrier
system
effici
exert
activ
nucleic
acidbas
tool
drug
reach
cellular
target
gain
entri
cell
recent
review
see
claim
proof
principl
particular
cpp
approach
might
suffici
measur
uptak
given
function
nucleic
acid
cargo
eg
sirna
aptam
antisens
rna
howev
provid
inform
biolog
activ
cargo
thu
sidebysid
analysi
cargo
internalis
correspond
biolog
effect
requir
determin
overal
efficaci
system
adapt
highli
sensit
method
describ
overhoff
et
al
quantif
sirna
enabl
us
detect
intracellular
sirna
amount
copi
per
cell
method
base
liquid
hybridis
radioact
label
probe
correspond
antisens
strand
sirna
cellular
lysat
addit
stringent
wash
procedur
absolut
requir
alreadi
outlin
complex
strongli
attach
cell
surfac
often
underestim
sourc
misinterpret
true
amount
cargo
taken
cell
implement
heparin
wash
could
reduc
overal
amount
allegedli
intracellular
sirna
result
impress
show
import
procedur
oppos
major
cpp
applic
report
reli
coval
linkag
carrier
cargo
use
studi
peptid
term
deriv
origin
mpg
peptid
describ
morri
cowork
peptid
form
highli
stabl
noncoval
complex
nucleic
acid
differ
mpg
six
amino
acid
hydrophob
part
chang
result
alter
overal
structur
peptid
toward
higher
tendenc
adopt
helic
conform
accordingli
two
peptid
behav
differ
respect
interact
artifici
lipid
well
xenopu
oocyt
confus
probabl
exact
mechan
uptak
deliveri
anti
luciferas
complex
hela
cell
yield
nm
figur
although
number
alon
alreadi
quit
impress
convincingli
show
approach
work
well
cell
cultur
experi
provid
inform
percentag
bioavail
sirna
taken
compar
amount
extracellular
rna
amount
rna
internalis
becom
obviou
less
enter
cell
howev
even
remark
data
deriv
comparison
microinject
experi
indic
less
molecul
taken
enter
rnai
machineri
thu
vast
major
molecul
probabl
physic
state
suitabl
trigger
rnai
confoc
microscopi
studi
fluoresc
label
oligonucleotid
reveal
punctual
cytoplasmat
distribut
molecul
mediat
uptak
figur
togeth
data
describ
data
concern
effect
specif
inhibitorseffector
differ
endocytot
pathway
strongli
indic
endocytosi
involv
uptak
accordingli
would
feasibl
liber
sirna
molecul
trap
vesicular
compart
one
would
abl
dramat
boost
overal
efficaci
approach
though
other
report
similar
find
studi
first
time
put
number
much
room
improv
actual
altogeth
data
present
clearli
show
enorm
potenti
particular
cppmediat
cellular
deliveri
sirna
like
true
variou
degre
similar
approach
well
time
reveal
problem
resolv
futur
owe
recent
critic
evalu
mechan
underli
cellular
transloc
cpp
becom
appar
technic
shortcom
caus
fals
assumpt
led
overestim
transloc
effici
well
misinterpret
concern
cellular
uptak
mechan
consequ
effort
improv
cpp
transfect
effici
might
hamper
even
wors
went
wrong
direct
meanwhil
mani
problem
identifi
major
present
studi
implement
latest
technic
achiev
combin
varieti
complementari
method
today
consider
evid
endocytosi
involv
internalis
process
variou
cpp
inform
exact
mechan
uptak
collect
increas
rate
signific
improv
deliveri
system
expect
near
futur
hand
current
avail
data
base
studi
use
varieti
differ
cell
line
techniqu
render
direct
comparison
differ
cpp
imposs
therefor
would
highli
desir
establish
standardis
report
system
would
facilit
quantit
analysi
exceedingli
divers
approach
furthermor
shown
even
minor
chang
physic
state
cpp
eg
exchang
certain
amino
acid
alter
transloc
properti
significantli
particularli
hold
true
attach
larg
cargo
molecul
thu
might
possibl
generalis
result
obtain
given
cpp
might
necessari
characteris
carriercargo
complex
individu
cpp
intend
use
therapeut
purpos
futur
essenti
focu
attach
function
cargo
analys
biolog
effect
insid
cell
data
lab
clearli
show
uptak
biolog
activ
function
cargo
everyth
therefor
quantit
comparison
cargo
taken
function
activ
cargo
essenti
requir
order
improv
therapeut
efficaci
look
effici
internalis
suffici
prerequisit
need
sensit
easi
handl
report
system
combin
sensit
method
quantifi
intracellular
amount
cargo
like
one
sirna
briefli
describ
data
establish
system
deliveri
sirna
well
number
recent
studi
review
strongli
suggest
endosom
accumul
cargo
uptak
per
se
bottleneck
approach
thu
resolv
problem
endosom
escap
current
main
challeng
cppsystem
conclus
current
report
provid
increas
evid
peptid
repres
promis
altern
viral
lipidbas
nucleic
acid
deliveri
system
two
decad
intens
research
chose
constantli
grow
arsen
differ
peptidebas
transfect
system
suitabl
particular
applic
nucleic
acid
deliveri
vitro
simpl
peptid
carrier
probabl
first
choic
describ
noncoval
approach
offer
degre
flexibl
requir
basic
research
applic
experiment
condit
may
chang
frequent
vivo
applic
trend
toward
complex
elabor
system
see
chapter
polym
complex
system
clearli
seen
approach
promis
individu
resolv
import
issu
like
undesir
degrad
clearanc
bodi
target
cell
specif
